News | Heart Failure | March 11, 2022

Lab-grown Pig Heart Tissue Could Help Replace Live Animals in Heart Disease Research

Researchers have developed a process that involves obtaining and growing thin slices of pig heart tissue which include both the epicardium and underlying heart muscle. 

A new way to replicate what happens inside the heart after cardiac arrest could open new avenues for the study of heart regeneration whilst reducing the use of live animals in research, according to a study from the University of Surrey and King’s College London. 

Getty Images


March 13, 2022 – A new way to replicate what happens inside the heart after cardiac arrest could open new avenues for the study of heart regeneration whilst reducing the use of live animals in research, according to a study from the University of Surrey and King’s College London

Researchers have developed a process that involves obtaining and growing thin slices of pig heart tissue which include both the epicardium – the most external layer of the heart that contains cells that can promote its recovery – and underlying heart muscle. 

The team treated the epicardial slices with stimulating compounds, showing that cells become activated in a way that replicates what happens in the heart after a heart attack. The new process was able to reproduce observations typically obtained in live animal models. 

Dr Paola Campagnolo, lead author of the study and Senior Lecturer in Molecular Cardiovascular Sciences at the University of Surrey, said: “This research typifies the One Health, One Medicine ethos at the University of Surrey, as our model could help us understand how to stimulate the repair process after heart attacks without the need to use live animals in the research. We are hopeful our model could lead to better health outcomes for humans and reduce the reliance on animal experiments in cardiovascular science.” 

According to the British Heart Foundation, there are around 7.6 million people living with heart or circulatory disease in the UK. This disease causes a quarter of all deaths in the UK. 

The ability of the heart to recover after an injury is severely limited by the low number of regenerating cells within its tissue. The current research models and strategies aimed at improving the heart’s repair process are mainly based on surgical procedures performed on laboratory animals.  

Dr Davide Maselli, Postdoctoral Research Associate and first author of the paper, said: “This work provides an innovative tool to study the healing from a heart attack. We believe that our model could be useful to dissect the role of different cells in the reparative process. In our consideration, it is extremely important that every step forward in this field delivers a clinical perspective for the patients while reducing the burden on research animals.” 

The research, published in the journal npj Regenerative Medicine, proposes a system to study the regeneration of the heart in a laboratory dish and could therefore lead to a reduction in the number of small animals used in cardiovascular research. 

For more information: https://www.bhf.org.uk/

Related Heart Transplant News:

Pig Heart Transplant Patient Continues to Thrive

First Human Receives a Pig Heart Transplant

Transplanting Pig Hearts Into Humans One Step Closer

FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study

Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow

Heart in a Box Technology Expands Heart Transplant Window

Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’s Breakthrough Device Designation

FDA Clears SynCardia 50cc Temporary Total Artificial Heart as Bridge to Transplant

Stephanie’s Heart: The Story of Baby Fae

Hearts from donors who used illicit drugs or overdosed safe for transplant, cuts wait time

National Trends in Heart Donor Utilization Rates: Are We Efficiently Transplanting More Hearts?

Heart transplants from donors with hepatitis C may be safe and could help decrease organ shortage

Find more cardiac surgery technology content

Find more heart failure technology content


Related Content

News | Heart Failure

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million ...

Home June 07, 2024
Home
News | Heart Failure

June 7, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home June 07, 2024
Home
News | Heart Failure

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
Subscribe Now